Publicaciones (334) Publicaciones de Fernando Jesús Antoñanzas Villar

2024

  1. Cost-Effectiveness Analysis of Vaccines for COVID-19 According to Sex, Comorbidity and Socioeconomic Status: A Population Study

    PharmacoEconomics, Vol. 42, Núm. 2, pp. 219-229

2023

  1. Cost of lost productivity from acute respiratory infections in South America

    Revista Panamericana de Salud Publica/Pan American Journal of Public Health, Vol. 47

  2. Does diagnostic testing always decrease antibiotics prescriptions?

    European Journal of Health Economics, Vol. 24, Núm. 5, pp. 673-678

  3. Tenders for generics and biosimilars: a challenging purchasing policy

    European Journal of Health Economics

  4. The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approach

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 23, Núm. 4, pp. 431-438

2022

  1. Burden of disease attributed to acute respiratory infections in South America

    Journal of Infection in Developing Countries, Vol. 16, Núm. 10, pp. 1614-1622

  2. Diagnostic testing for sepsis: A systematic review of economic evaluations

    Antibiotics, Vol. 11, Núm. 1

  3. Seeking efficiency gains outside drugs and diagnostics

    European Journal of Health Economics

2021

  1. A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study)

    Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1

  2. Analysis of the prescription of antibiotics during the implementation of COVID-19 personal protection measures in a regional health system

    ClinicoEconomics and Outcomes Research, Vol. 13, pp. 927-936

  3. Drug prices in Latin American countries: the case of rheumatoid arthritis Biosimilars

    Advances in Rheumatology, Vol. 61, Núm. 1

  4. Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review

    PharmacoEconomics, Vol. 39, Núm. 12, pp. 1411-1427

  5. Efficiency of diagnostic testing for helicobacter pylori infections—a systematic review

    Antibiotics, Vol. 10, Núm. 1, pp. 1-11

  6. Health-Economic Analyses of Diagnostics: Guidance on Design and Reporting

    PharmacoEconomics, Vol. 39, Núm. 12, pp. 1355-1363

  7. Hispa-NICE: A Pipe Dream or a Realistic and Necessary Initiative?

    PharmacoEconomics

  8. Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model

    Health Economics Review, Vol. 11, Núm. 1

2020

  1. Assessment of the quality of antibiotics prescription in a regional health system

    Revista Clínica Española

  2. Availability of biological cancer drugs under research: Registration and price in Brazil, Colombia, and Mexico

    Physis, Vol. 30, Núm. 4, pp. 1-22

  3. Effects of economic and health policies on the consumption of antibiotics in a Spanish region

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 20, Núm. 4, pp. 379-386

  4. Efficiency ratio and rocketing drug prices: old concerns and new possibilities

    European Journal of Health Economics